Mitochondrial Cocktail for Gulf War Illness

Completed · Not applicable · Has a placebo group

Conditions studied: Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorders

In brief

The purpose of this study is to develop preliminary evidence, such as effect size and variance estimates, to guide successful conduct of a properly-powered clinical trial to assess the benefit of a mitochondrial cocktail (incorporating individualization of treatment) in Gulf War illness (GWI).

Key facts

Study ID

NCT02804828

Run by

University of California, San Diego

People needed

15

Starts

2021-04-09

Expected to finish

2023-04-03

Last updated by the study team

2023-04-05

Who can join

Age: 48 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet symptom criteria for Gulf War illness with BOTH the Centers for Disease Control and Prevention (CDC) Criteria (persistent symptoms in at least 2 of 3 designated symptom domains of fatigue/sleep, mood/cognition, and musculoskeletal) and Kansas Criteria (score a moderate or severe rating in at least 3 of the 6 symptom domains of fatigue, pain, neurological/cognitive/mood, skin, GI and respiratory).

You may not qualify if…

• Have conditions like multiple sclerosis or lupus that can produce similar symptoms and be confused for Gulf War illness.
• Participating in a concurrent treatment trial.
• Unwilling or unable to comply with the treatment protocol
• Failed run-in; do not take at least 80% of run-in medications

Where it is running

• UC San Diego — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.